Latest News and Press Releases

Eco Bright Future, Inc.'s Director, Tomax Strgar, Provides a Letter to Shareholders

New York, NY, Sept. 20, 2022 (GLOBE NEWSWIRE) -- 8B Education Investments partners with Nelnet Bank in the first ever lending program by a US bank to African students enrolled in American...

Philadelphia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Recently, Fattah Neuroscience Global Advisors LLC (FNGA), a consulting firm founded by former U.S. Congressman Chaka Fattah, Sr., committed to...

CALGARY, Alberta, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the Company”) (TSX: RVX), a world leader in epigenetics or gene regulation, is pleased to announce today that...

PISCATAWAY, N.J., July 16, 2019 (GLOBE NEWSWIRE) -- Hammer Fiber Optics Holdings Corp’s (OTCQB: HMMR) announced today that it has expanded its Over-the-Top services. The 1P-SMSC, offered by Hammer’s...

In a release issued under the same headline earlier today by Immune Therapeutics, Inc. (OTCQB:IMUN), the headline has been corrected to read "Immune Therapeutics Announces NAFDAC Approval...

Highlights: National Agency for Food and Drug Administration and Control (“NAFDAC”) approval paves way for Immune Therapeutics’ first significant revenue channel Immune Therapeutics’ goal to capture...

ORLANDO, Fla., April 25, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using LodonalTM...

ORLANDO, Fla., April 12, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using LodonalTM,...

ORLANDO, Fla., March 17, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using Lodonal™,...